Nyarko A K, Kellner-Weibel G L, Harvison P J
Chemical Pathology Unit, Noguchi Memorial Institute, University of Ghana, Legon-Accra, Ghana.
Fundam Appl Toxicol. 1997 Jun;37(2):117-24. doi: 10.1006/faat.1997.2321.
The agricultural fungicide N-(3,5-dichlorophenyl)succinimide (NDPS) is nephrotoxic in rats. Previous studies have suggested that oxidative hepatic biotransformation is required for the induction of kidney damage. The experiments described in this paper were designed to further investigate the relationship between NDPS metabolism and nephrotoxicity using various modulators of cytochrome P450 activity. Male Fischer 344 rats were pretreated with the P450 inducers Aroclor 1254 (ARO), isoniazid (INH), 3-methylcholanthrene (3-MC), and phenobarbital (PB), or the P450 inhibitor 1-aminobenzotriazole (ABT). Control animals received vehicle only. NDPS metabolism was investigated using hepatocytes isolated from the various treatment groups. Separate experiments were also conducted to evaluate the effects of these pretreatments on NDPS-induced nephrotoxicity in rats. PB and ARO enhanced formation of the known nephrotoxic NDPS metabolites, N-(3,5-dichlorophenyl)-2-hydroxysuccinimide, N-(3,5-dichlorophenyl)-2-hydroxysuccinamic acid, and N-(3,5-dichlorophenyl)-3-hydroxysuccinamic acid, by the hepatocytes. In contrast, ABT inhibited formation of the nephrotoxic metabolites, whereas INH and 3-MC did not alter NDPS biotransformation. NDPS-induced renal damage was potentiated by pretreating the rats with PB or ARO and was attenuated by ABT. Compared with control animals, toxicity was unaffected by INH or 3-MC pretreatments. Thus, there was a correlation between pretreatments that induce P450-mediated NDPS metabolism and the effects that these compounds have on NDPS-induced nephrotoxicity. The data indicate that specific P450 isozymes metabolize NDPS to its hydroxylated products and suggest that these metabolites mediate the nephrotoxicity induced by NDPS.
农业杀菌剂N-(3,5-二氯苯基)琥珀酰亚胺(NDPS)对大鼠具有肾毒性。先前的研究表明,肝脏氧化生物转化是诱导肾脏损伤所必需的。本文所述实验旨在使用细胞色素P450活性的各种调节剂,进一步研究NDPS代谢与肾毒性之间的关系。雄性Fischer 344大鼠用P450诱导剂多氯联苯(ARO)、异烟肼(INH)、3-甲基胆蒽(3-MC)和苯巴比妥(PB),或P450抑制剂1-氨基苯并三唑(ABT)进行预处理。对照动物仅接受赋形剂。使用从各个治疗组分离的肝细胞研究NDPS代谢。还进行了单独的实验,以评估这些预处理对大鼠中NDPS诱导的肾毒性的影响。PB和ARO增强了肝细胞对已知肾毒性NDPS代谢物N-(3,5-二氯苯基)-2-羟基琥珀酰亚胺、N-(3,5-二氯苯基)-2-羟基琥珀酰胺酸和N-(3,5-二氯苯基)-3-羟基琥珀酰胺酸的形成。相比之下,ABT抑制肾毒性代谢物的形成,而INH和3-MC不改变NDPS生物转化。用PB或ARO预处理大鼠可增强NDPS诱导的肾损伤,而ABT可减轻肾损伤。与对照动物相比,INH或3-MC预处理不影响毒性。因此,诱导P450介导的NDPS代谢的预处理与这些化合物对NDPS诱导的肾毒性的影响之间存在相关性。数据表明,特定P450同工酶将NDPS代谢为其羟基化产物,并表明这些代谢物介导了NDPS诱导的肾毒性。